Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Mineralys Therapeutics (MLYS)

Mineralys Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MLYS
DateTimeSourceHeadlineSymbolCompany
25/09/202413:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
25/09/202413:00GlobeNewswire Inc.Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of HypertensionNASDAQ:MLYSMineralys Therapeutics Inc
13/08/202421:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MLYSMineralys Therapeutics Inc
13/08/202421:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
13/08/202421:05GlobeNewswire Inc.Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:MLYSMineralys Therapeutics Inc
05/08/202421:05GlobeNewswire Inc.Mineralys Therapeutics to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024NASDAQ:MLYSMineralys Therapeutics Inc
17/06/202421:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MLYSMineralys Therapeutics Inc
17/06/202421:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MLYSMineralys Therapeutics Inc
14/06/202413:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
14/06/202413:00GlobeNewswire Inc.Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of DirectorsNASDAQ:MLYSMineralys Therapeutics Inc
10/06/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
31/05/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
23/05/202421:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MLYSMineralys Therapeutics Inc
22/05/202421:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
09/05/202412:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MLYSMineralys Therapeutics Inc
09/05/202412:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
09/05/202412:00GlobeNewswire Inc.Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:MLYSMineralys Therapeutics Inc
06/05/202413:00GlobeNewswire Inc.Mineralys Therapeutics to Participate in the Bank of America Securities Health Care ConferenceNASDAQ:MLYSMineralys Therapeutics Inc
02/05/202413:00GlobeNewswire Inc.Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024NASDAQ:MLYSMineralys Therapeutics Inc
21/03/202411:00GlobeNewswire Inc.Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:MLYSMineralys Therapeutics Inc
13/03/202420:05GlobeNewswire Inc.Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024NASDAQ:MLYSMineralys Therapeutics Inc
15/02/202421:20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MLYSMineralys Therapeutics Inc
08/02/202421:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
08/02/202413:00GlobeNewswire Inc.Mineralys Therapeutics Announces $120 Million Private Placement FinancingNASDAQ:MLYSMineralys Therapeutics Inc
29/01/202421:05GlobeNewswire Inc.Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology ConferenceNASDAQ:MLYSMineralys Therapeutics Inc
04/01/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
04/01/202421:05GlobeNewswire Inc.Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business OfficerNASDAQ:MLYSMineralys Therapeutics Inc
22/12/202314:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
21/12/202321:05GlobeNewswire Inc.Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of HypertensionNASDAQ:MLYSMineralys Therapeutics Inc
13/11/202313:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MLYS

Your Recent History

Delayed Upgrade Clock